255 related articles for article (PubMed ID: 11601895)
1. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
Gonçalves MA; Pau MG; de Vries AA; Valerio D
Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
[TBL] [Abstract][Full Text] [Related]
2. Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors.
Gonçalves MA; van der Velde I; Knaän-Shanzer S; Valerio D; de Vries AA
Virology; 2004 Apr; 321(2):287-96. PubMed ID: 15051388
[TBL] [Abstract][Full Text] [Related]
3. Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors.
Gonçalves MA; van der Velde I; Janssen JM; Maassen BT; Heemskerk EH; Opstelten DJ; Knaän-Shanzer S; Valerio D; de Vries AA
J Virol; 2002 Nov; 76(21):10734-44. PubMed ID: 12368316
[TBL] [Abstract][Full Text] [Related]
4. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
Li C; Samulski RJ
Virology; 2005 Apr; 335(1):10-21. PubMed ID: 15823602
[TBL] [Abstract][Full Text] [Related]
5. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
6. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
7. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
8. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
[TBL] [Abstract][Full Text] [Related]
9. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus.
Rabinowitz JE; Xiao W; Samulski RJ
Virology; 1999 Dec; 265(2):274-85. PubMed ID: 10600599
[TBL] [Abstract][Full Text] [Related]
10. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
Dong JY; Fan PD; Frizzell RA
Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
[TBL] [Abstract][Full Text] [Related]
12. In vitro packaging of an infectious recombinant adeno-associated virus 2.
Ding L; Lu S; Munshi NC
Gene Ther; 1997 Nov; 4(11):1167-72. PubMed ID: 9425439
[TBL] [Abstract][Full Text] [Related]
13. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
Clark KR; Voulgaropoulou F; Johnson PR
Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
[TBL] [Abstract][Full Text] [Related]
14. Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios.
Aucoin MG; Perrier M; Kamen AA
Biotechnol Bioeng; 2006 Dec; 95(6):1081-92. PubMed ID: 16952153
[TBL] [Abstract][Full Text] [Related]
15. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
[TBL] [Abstract][Full Text] [Related]
16. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.
Grimm D; Kern A; Pawlita M; Ferrari F; Samulski R; Kleinschmidt J
Gene Ther; 1999 Jul; 6(7):1322-30. PubMed ID: 10455443
[TBL] [Abstract][Full Text] [Related]
17. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
18. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
[TBL] [Abstract][Full Text] [Related]
19. Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
Jayandharan GR; Zhong L; Li B; Kachniarz B; Srivastava A
Gene Ther; 2008 Sep; 15(18):1287-93. PubMed ID: 18496572
[TBL] [Abstract][Full Text] [Related]
20. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
